A Phase II Trial of Bicalutamide in Patients Receiving Intravesical BCG for Non-muscle Invasive Bladder Cancer
Clinical trial NCT05327647 · RECRUITING
Trial details
- NCT number
- NCT05327647
- Sponsor
- CHU de Quebec-Universite Laval
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-23
- Primary completion
- 2026-09-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.